{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:51:30Z","timestamp":1791352290504,"version":"4.3.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":308,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100009754","name":"Galderma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009754","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/bjd.13191","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T00:56:28Z","timestamp":1402966588000},"page":"1508-1516","source":"Crossref","is-referenced-by-count":45,"title":["A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene\/benzoyl peroxide plus doxycycline vs. oral isotretinoin"],"prefix":"10.1093","volume":"171","author":[{"given":"J.","family":"Tan","sequence":"first","affiliation":[{"name":"University of Western Ontario and Windsor Clinical Research Inc.; 2224 Walker Rd. Suite 300 Windsor ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Humphrey","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science; The University of British Columbia; Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vender","sequence":"additional","affiliation":[{"name":"Dermatrials Research Inc.; Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Barankin","sequence":"additional","affiliation":[{"name":"Toronto Research Centre; Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gooderham","sequence":"additional","affiliation":[{"name":"SKiN Centre for Dermatology; Peterborough ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kerrouche","sequence":"additional","affiliation":[{"name":"Galderma R&D SNC; Sophia Antipolis France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Audibert","sequence":"additional","affiliation":[{"name":"Galderma R&D SNC; Sophia Antipolis France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lynde","sequence":"additional","affiliation":[{"name":"Lynderm Clinical Research; Markham ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the POWER study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,28]]},"reference":[{"key":"10.1111\/bjd.13191-BIB0001|bjd13191-cit-0001","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13191-BIB0002|bjd13191-cit-0002","first-page":"565","article-title":"An expert view on the treatment of acne with systemic antibiotics and\/or oral isotretinoin in the light of the new European recommendations","volume":"16","author":"Dr\u00e9no","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.13191-BIB0003|bjd13191-cit-0003","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1468-3083.2006.01671.x","article-title":"A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris","volume":"20","author":"Layton","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13191-BIB0004|bjd13191-cit-0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000017844","article-title":"Topical drug treatment in acne","volume":"196","author":"Gollnick","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/bjd.13191-BIB0005|bjd13191-cit-0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003495-199753030-00010","article-title":"Adapalene: a review of its pharmacological properties and clinical potential in the management of mild to moderate acne","volume":"53","author":"Brogden","year":"1997","journal-title":"Drugs"},{"issue":"Suppl. 52","key":"10.1111\/bjd.13191-BIB0006|bjd13191-cit-0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2133.1998.1390s2003.x","article-title":"Pharmacology of adapalene","volume":"139","author":"Michel","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13191-BIB0007|bjd13191-cit-0007","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0190-9622(97)70050-1","article-title":"Pharmacology and chemistry of adapalene","volume":"36","author":"Shroot","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 3","key":"10.1111\/bjd.13191-BIB0008|bjd13191-cit-0008","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1046\/j.0926-9959.2001.00013.x","article-title":"Current issues in antimicrobial therapy for the treatment of acne","volume":"15","author":"Leyden","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.13191-BIB0009|bjd13191-cit-0009","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","article-title":"Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicentre, randomized double-blind, controlled study","volume":"57","author":"Thiboutot","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13191-BIB0010|bjd13191-cit-0010","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-2133.2009.09209.x","article-title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients","volume":"161","author":"Gollnick","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13191-BIB0011|bjd13191-cit-0011","first-page":"110","article-title":"A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Gold","year":"2009","journal-title":"Cutis"},{"key":"10.1111\/bjd.13191-BIB0012|bjd13191-cit-0012","first-page":"899","article-title":"Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris","volume":"6","author":"Pariser","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.13191-BIB0013|bjd13191-cit-0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/09546631003681094","article-title":"Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients","volume":"22","author":"Tan","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.13191-BIB0014|bjd13191-cit-0014","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jaad.2010.03.036","article-title":"The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions","volume":"64","author":"Feldman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13191-BIB0015|bjd13191-cit-0015","first-page":"94","article-title":"Effective and safe combination therapy for severe acne vulgaris: a randomized, vehicle-controlled, double-blind study of adapalene 0.1%-benzoyl peroxide 2.5% fixed-dose combination gel with doxycycline hyclate 100\u00a0mg","volume":"85","author":"Gold","year":"2010","journal-title":"Cutis"},{"key":"10.1111\/bjd.13191-BIB0016|bjd13191-cit-0016","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JB.133.2.811-815.1978","article-title":"Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum","volume":"133","author":"Lee","year":"1978","journal-title":"J Bacteriol"},{"key":"10.1111\/bjd.13191-BIB0017|bjd13191-cit-0017","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1157\/13116656","article-title":"Composite endpoints in clinical trials","volume":"61","author":"Ferreira-Gonz\u00e1lez","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"10.1111\/bjd.13191-BIB0018|bjd13191-cit-0018","first-page":"538","article-title":"Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne","volume":"11","author":"Gollnick","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.13191-BIB0019|bjd13191-cit-0019","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2340\/00015555-0211","article-title":"Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris","volume":"87","author":"Oprica","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.13191-BIB0020|bjd13191-cit-0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000249321","article-title":"Isotretinoin versus minocycline in cystic acne: a study of lipid metabolism","volume":"172","author":"Pigatto","year":"1986","journal-title":"Dermatologica"},{"key":"10.1111\/bjd.13191-BIB0021|bjd13191-cit-0021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4362.1985.tb05458.x","article-title":"Isotretinoin and tetracycline in the management of severe nodulocystic acne","volume":"24","author":"Lester","year":"1985","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.13191-BIB0022|bjd13191-cit-0022","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mjd.2001.115966","article-title":"Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: a randomized trial comparing micronized isotretinoin with standard isotretinoin","volume":"45","author":"Strauss","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13191-BIB0023|bjd13191-cit-0023","unstructured":"Center for Drug Evaluation and Research FDA Clinical review 21-951 Cipher Pharmaceuticals Inc http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2012\/021951Orig1s000MedR.pdf"},{"key":"10.1111\/bjd.13191-BIB0024|bjd13191-cit-0024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajog.2006.10.903","article-title":"Composite outcomes in randomized clinical trials: arguments for and against","volume":"196","author":"Ross","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13191","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13191\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T09:14:14Z","timestamp":1689326054000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/6\/1508\/6616256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,28]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13191","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,28]]}}}